Literature DB >> 10217467

Reversible congestive heart failure caused by myocardial hibernation.

J M Wilson1.   

Abstract

Myocardial hibernation is reversible contractile dysfunction of cardiac myocytes caused by chronic ischemia. Animal studies and observations in human beings suggest that the term hibernation is a misnomer. Repetitive ischemic insult that does not produce necrosis results in functional and histologic tissue deterioration, which culminates in myocyte apoptosis. Revascularization of "hibernating" myocardium results in partial or complete recovery of function, depending upon the duration of ischemia and the severity of cellular degeneration. Improvement in global left ventricular function is proportional to the quantity of hibernating tissue that is revascularized, but this threshold quantity has not been determined with certainty. Diagnostic methods used to detect viable tissue within akinetic left ventricular segments depend upon the recognition of recruitable contractile function or the active concentration of a radioactive tracer. No diagnostic method has shown clear superiority. The most sensitive methods appear to be single-photon emission computed tomographic imaging after reinjection of thallium-201 at 24 hours and positron-emission tomographic imaging with 18F-fluorodeoxyglucose. The most specific diagnostic method appears to be measurement of dobutamine-stimulated contractile function, using either echocardiography or gated magnetic resonance imaging. We present a review of the pathophysiology, diagnosis, and treatment of myocardial hibernation, and include an illustrative case report involving a 57-year-old man with myocardial hibernation.

Entities:  

Mesh:

Year:  1999        PMID: 10217467      PMCID: PMC325595     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  54 in total

1.  Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia.

Authors:  P H McNulty; A J Sinusas; C Q Shi; D Dione; L H Young; G C Cline; G I Shulman
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Detection of myocardial viability in the prediction of improvement in left ventricular function after successful coronary revascularization by using the dobutamine stress echocardiography and quantitative SPECT rest-redistribution-reinjection 201TI imaging after dipyridamole infusion.

Authors:  K G Kostopoulos; A I Kranidis; K P Bouki; J P Antonellis; K G Kappos; F E Rodogianni; N J Zamanis; A G Tavernarakis; C T Lolas; L P Anthopoulos
Journal:  Angiology       Date:  1996-11       Impact factor: 3.619

3.  Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography.

Authors:  J J Bax; J H Cornel; F C Visser; P M Fioretti; A van Lingen; A E Reijs; E Boersma; G J Teule; C A Visser
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

4.  Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation.

Authors:  J Ausma; D Fürst; F Thoné; B Shivalkar; W Flameng; K Weber; F Ramaekers; M Borgers
Journal:  J Mol Cell Cardiol       Date:  1995-05       Impact factor: 5.000

5.  Hibernating myocardium: clinical and functional response to revascularisation.

Authors:  M G Gunning; T P Chua; D Harrington; C J Knight; E Burman; D J Pennell; J Pepper; K Fox; S R Underwood
Journal:  Eur J Cardiothorac Surg       Date:  1997-06       Impact factor: 4.191

6.  Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography.

Authors:  S F Nagueh; P Vaduganathan; N Ali; A Blaustein; M S Verani; W L Winters; W A Zoghbi
Journal:  J Am Coll Cardiol       Date:  1997-04       Impact factor: 24.094

7.  Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.

Authors:  J L Vanoverschelde; A M D'Hondt; T Marwick; B L Gerber; M De Kock; R Dion; W Wijns; J A Melin
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

8.  Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease.

Authors:  C R deFilippi; D L Willett; W N Irani; E J Eichhorn; C E Velasco; P A Grayburn
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

9.  The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.

Authors:  R T Go; W J MacIntyre; S A Cook; D R Neumann; R C Brunken; G B Saha; D A Underwood; T H Marwick; E Q Chen; J L King; S Khandekar
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

10.  Myocyte degeneration and cell death in hibernating human myocardium.

Authors:  E R Schwarz; J Schaper; J vom Dahl; C Altehoefer; B Grohmann; F Schoendube; F H Sheehan; R Uebis; U Buell; B J Messmer; W Schaper; P Hanrath
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094

View more
  1 in total

Review 1.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.